Rapper Yoon Byung-ho, who performs under the stage name Bully Da Ba$tard, will release a new EP, "Already," on Saturday.

Celltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.